Stocks and Investing Stocks and Investing
Fri, February 18, 2022
[ 12:00 AM ] - WOPRAI
Matthew Mishan Maintained (BAX) at Buy with Decreased Target to $95 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Jayson Bedford Maintained (BAX) at Buy with Decreased Target to $96 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (BAX) at Buy with Decreased Target to $105 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (AMG) at Strong Buy with Decreased Target to $183 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Whit Mayo Maintained (AMED) at Hold with Increased Target to $147 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (CBOE) at Strong Buy with Decreased Target to $143 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (STT) at Strong Buy with Decreased Target to $130 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Balaji Prasad Maintained (TEVA) at Hold with Decreased Target to $11 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (TROW) at Hold with Decreased Target to $159 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Duffy Fischer Maintained (TROX) at Buy with Increased Target to $27 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Ju Maintained (TRIP) at Hold with Decreased Target to $30 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Connor Lynagh Maintained (TS) at Buy with Increased Target to $32 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Piyush Mubayi Downgraded (TME) to Strong Sell and Decreased Target to $5.7 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Beth Reed Maintained (TJX) at Strong Buy with Decreased Target to $88 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Lauren Lieberman Maintained (CCEP) at Buy with Decreased Target to $74 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Ross Fowler Initiated (CEG) at Hold and Held Target at $50 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (SR) at Hold with Decreased Target to $65 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (SRE) at Hold with Decreased Target to $76 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (SO) at Sell with Decreased Target to $61 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Altobello Maintained (YETI) at Buy with Decreased Target to $86 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Randal Konik Maintained (YETI) at Strong Buy with Decreased Target to $120 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Peter Benedict Maintained (YETI) at Buy with Decreased Target to $90 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Johnson Maintained (XRAY) at Buy with Decreased Target to $67 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Ben Haynor Upgraded (TTOO) to Strong Buy on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Brian Bedell Maintained (TW) at Hold with Decreased Target to $87 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (TYL) at Buy with Decreased Target to $540 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Joe Goodwin Maintained (TYL) at Buy and Held Target at $540 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Alex Zukin Maintained (TYL) at Buy with Decreased Target to $500 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Lauren Silberman Maintained (USFD) at Buy with Increased Target to $46 on, Feb 18th, 2022
[ 12:00 AM ] - WOPRAI
Luca Issi Initiated (VERV) at Buy and Held Target at $42 on, Feb 18th, 2022

Luca Issi Initiated (VERV) at Buy and Held Target at $42 on, Feb 18th, 2022


Published on 2024-10-27 19:44:43 - WOPRAI, Luca Issi
  Print publication without navigation


Luca Issi of RBC Capital, Initiated "Verve Therapeutics, Inc." (VERV) at Buy and Held Target at $42 on, Feb 18th, 2022.

Luca, nor any peers, have made any analyst calls on VERV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources